Products

Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: parvus
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    248522

    Product Name Bungarus Parvus Veterinary Grade API
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Intended Use Veterinary applications
    Appearance Varies with dosage form (powder, solution, solid forms)
    Purity Typically ≥ 98%
    Solubility Form-dependent; water or saline for solutions
    Storage Conditions Store in a cool, dry place away from light
    Shelf Life 24-36 months under recommended storage
    Packaging Bulk containers or sterile vials depending on dosage form
    Species Targeted Livestock and companion animals
    Regulatory Status Complies with veterinary pharmaceutical standards
    Route Of Administration Oral or injectable depending on form
    Active Ingredient Content Standardized per batch as per veterinary guidelines

    As an accredited Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging is a sealed, tamper-proof 1 kg aluminum foil pouch, labeled for Bungarus Parvus Veterinary Grade API, pharmaceutical use only.
    Shipping The chemical "Bungarus Parvus Veterinary Grade API" is securely packed in sealed, tamper-evident containers suitable for tablets, injections, capsules, powders, granules, premix, and solutions. Each shipment includes proper labeling, safety documentation, and is shipped under temperature-controlled conditions to ensure product integrity and compliance with international shipping regulations.
    Storage **Storage Description:** Store Bungarus Parvus Veterinary Grade API in a tightly sealed container, protected from light, moisture, and incompatible substances. Maintain at room temperature (15–30°C) in a dry, well-ventilated area, away from heat sources and direct sunlight. Ensure storage is secure, clearly labeled, and restricted to authorized personnel only. Follow all local regulations and safety protocols for hazardous materials.
    Application of Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    As the original manufacturer, we supply Bungarus Parvus Veterinary Grade API to global animal health producers. Downstream factories incorporate our API into pharmaceutical forms under stringent controls to target specific veterinary indications. Below, we detail real-world applications across key industrial sectors where this API integrates into customer formulae, manufacturing, and compliance frameworks.

    1. Veterinary Injectable Antibiotics for Livestock

    Commercial veterinary drug manufacturers incorporate our API in sterile injectable formulations targeting bacterial and toxin-related infections, primarily in cattle, swine, and sheep. Production integrates upstream sterilization, aseptic filling, and tailored solvent compatibility, with each batch validated against regional pharmaceutical standards. Clients adjust formula concentrations to address animal weight, infection profile, and withdrawal requirements. Each campaign undergoes release via validated sterility and endotoxin tests to support regulatory market entry.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur.), monographs for veterinary APIs
    • China Veterinary Pharmacopoeia (CVP)
    • Good Manufacturing Practices for Veterinary Pharmaceuticals (GMPv)
    • FDA Guidance for Industry (US), especially for injectable parenterals

    Typical usage ratio

    • 2–10 mg/kg final use concentration, customized per animal species and pathogenic risk level; manufacturers routinely consult veterinary guidelines and adjust per product registration requirements.

    Downstream process integration

    • Bulk sterile API input post-micronization
    • Aseptic mixing with carrier solution (e.g., saline, polysorbate buffer)
    • Homogenization, pH correction, filtration, then aseptic vial filling
    • Final QC and batch certification prior to distribution

    Final product types

    • Single-dose and multi-dose vials for animal injection
    • Prefilled syringes for field veterinary use
    • Large-volume infusions for livestock production sites
    • Extended-release injectable microsphere formulations

    2. Veterinary Tablets for Companion Animal Prescription

    Pharmaceutical contract manufacturers and veterinary medicine firms use our API in direct compression or wet granulation tablet lines formulated for companion animals such as dogs and cats. These products deliver precise oral dosing for conditions such as envenomation-related muscle toxicity or neurotoxin management. Each batch aligns with published pharmacopoeial method validation, ensuring accurate impurity and dissolution profile monitoring. End users benefit from flavor-masked or chewable presentations to promote animal compliance.

    Industry compliance standards

    • United States Pharmacopeia (USP, veterinary chapter)
    • Good Manufacturing Practice (GMP) as per 21 CFR 211/210
    • ICH Q6A Specifications for New Drug Substances
    • Veterinary International Conference on Harmonisation (VICH) stability guidelines

    Typical usage ratio

    • 5–30 mg / tablet depending on targeted animal weight class and dosing schedule; final ratio established via regulatory pre-clinical report and labeling.

    Downstream process integration

    • API weighing, blending with excipients (lactose, microcrystalline cellulose, starch)
    • Direct compression or granulation prior to tableting
    • Optional flavoring or film coating stage
    • Blister packaging under humidity control for shelf-life

    Final product types

    • Scored and unscored tablets for oral dosing
    • Chewable tablets with palatants
    • Sustained-release multilayer tablets
    • Effervescent dissolvable veterinary tablets

    3. Animal Feed Premixes for Intensive Farming

    Major premix and feed additive factories utilize the API as a controlled ingredient within medicated feed blends. These inputs help control toxin-induced illnesses or secondary infections in intensive poultry or aquaculture operations. Stringent blending controls and analytical verification uphold uniform dosage-through-feed, with routine production audits for cross-contamination prevention. Downstream manufacturers track trace residues and withdrawal periods in finished feed under official agricultural supervision.

    Industry compliance standards

    • Codex Alimentarius for Medicated Feed
    • European Feed Additives and Premixtures Regulation (EC No 1831/2003)
    • Good Manufacturing Practice (Feed GMP+ 2020 standard)
    • FAMI-QS Code of Practice for Specialty Feed Ingredients

    Typical usage ratio

    • Active content typically 50–150 ppm in total premix, titrated based on target animal species and regional maximum residue limit (MRL) regulations.

    Downstream process integration

    • Powdered API addition during batch mixing phase
    • Multi-shaft homogenization for uniform content distribution
    • Quality assurance sampling for active content and carrier compatibility
    • Bulk tote filling or final packaging as granules/premix powders

    Final product types

    • Medicated feed premix concentrates for onsite farm blending
    • Poultry starter mash and grower feeds
    • Aquaculture medicated micro-pellets
    • Mineral-vitamin premix blends with toxin counteraction

    4. Oral Dosing Powders and Granules for Veterinary Hospital Use

    Specialty compounding sites and veterinary hospitals receive our API in micronized powder or granule formats for extemporaneous compounding. These forms enable individualized dosing regimens, especially in exotic animal practices or for non-standard species. Compounded mixtures align with written prescription protocols under regionally regulated pharmacy compounding frameworks. Finished powders often undergo further blending into flavored suspensions or divided sachets, maintaining traceability and strict documentation for clinical usage.

    Industry compliance standards

    • Compounding Standards (USP Chapter <795>/ <797> for pharmacy compounding)
    • Veterinary Compounding Compliance Policy Guide (FDA CPG Sec. 608.400)
    • British Pharmacopoeia Veterinary monographs
    • Good Compounding Practice (GCP) in veterinary settings

    Typical usage ratio

    • Customized 10–100 mg per individual animal dose; exact levels set by compounding pharmacist per prescription and body weight calculation.

    Downstream process integration

    • Micronized API received in sealed, validated containers
    • In-pharmacy weighing, subdivision, and mixing with carriers (lactose, dextrose, maltodextrin)
    • Packaging into unit-dose sachets or bulk jars for on-demand dispensing
    • Lot tracking and compounded product labeling with expiry and storage controls

    Final product types

    • Unit-dose powder sachets for oral use in diverse animal species
    • Custom-flavored powder blends for avian and reptile clinics
    • Granule servings for on-farm mixing and hand dosing
    • Exclusively compounded hospital batch packs

    Free Quote

    Competitive Bungarus Parvus Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Bungarus Parvus: Veterinary Grade API For Versatile Dosage Forms

    Reimagining Quality in Veterinary Pharmaceuticals

    After decades in the chemical manufacturing business, our team knows what veterinarians, formulators, and compounding specialists actually encounter on the production line. Bungarus Parvus, our veterinary grade active pharmaceutical ingredient, carries a legacy built with strict adherence to scientific rigor and hands-on industry insight. We deliver this API not just as another chemical, but as the result of continuous feedback, process refinements, and real-world problem solving.

    The Foundation: What Distinguishes Bungarus Parvus

    Years of R&D and feedback from veterinary manufacturers have shaped each batch of Bungarus Parvus. This API does not just meet specification; it is the result of process controls at every step, from raw material checks to particle size optimization and impurity profiling. Each batch is traceable and documented. Veterinary manufacturers value this traceability—problems trace back not to mysterious inconsistencies, but to real answers when something changes. Our chemical processes are backed by strong analytical support, including HPLC, GC, and micro-purity screening.

    Microbial limits, residual solvents, heavy metals—these are not checked as a box-ticking exercise. Our quality assurance process uses modern analytical instrumentation and retains full documentation for every critical point. Macroscopic homogeneity matters most when the daily reality in a mixing vessel is stubborn clumps, settling, or stratification. This is why our process includes controlled crystallization and gentle but thorough drying, protecting the integrity of each lot.

    Suitability Across Dosage Forms

    Veterinary medicines often require a broader set of delivery forms than their human counterparts. Bungarus Parvus fits directly into this framework. Tablet manufacturers require predictable compression; anyone who has grappled with capping or sticking recognizes the value in consistent flow and well-defined particle sizes. Capsule filling facilities rely on a powder that moves quickly yet resists static and bridging. Powders and granules, especially for feed mix use, need large-scale batch consistency—animal health outcomes depend on each animal getting the right amount, every day.

    For injectable solutions, subtle issues like incomplete dissolution or unrecognized particulate contamination can set back production runs. Each lot of Bungarus Parvus undergoes solubility and particulate characterization, so formulating teams do not lose days adjusting solvents or filtration steps. Granule and premix developers report improved yield and fewer rejections on final lot tests thanks to this material handling reliability.

    Model and Specifications in Real Practice

    On our production floor, specification means more than a certificate line item. Bungarus Parvus has a defined, narrow range for active content. Customers see repeatable assay values, not wide swings. Particle size, a persistent pain for many developers, is managed using sieving and air classification. From microfine grades between 10 and 50 micrometers on up to custom blends, we supply options without bottlenecking downstream production with mismatched flow or mixing properties.

    Routine impurity profiling reduces the risk of unanticipated side reactions in sensitive formulations. Chloride, sulfate, and trace metal levels stay below analytical detection thresholds, minimizing the risk of lot rejections from targeted veterinary standards and international export requirements.

    In Use: What Sets It Apart on the Production Line

    A real-world, production-grade API must support scaling. Our customers report direct blending of Bungarus Parvus into batch sizes from 10kg to several metric tons without shift-to-shift variability. Our API disperses evenly in liquid blends for injection. When going from pilot to commercial batches, physical handling characteristics (like bulk density and compressibility) hold stable, which cuts unplanned downtime and adjustments. Production QA teams value the batch-to-batch reproducibility.

    Unlike small-scale or research-grade alternatives, our process minimizes the risk of foreign matter, solves bulk storage stability problems, and carries a full audit trail from incoming raw material through packaging. Stability data under both accelerated (40°C/75%RH) and real-time conditions supports shelf life projections. This documentation solves many regulatory and customer audit issues before they arise.

    Differences From Other APIs on the Market

    All APIs for veterinary applications deliver labeled actives, but few offer the level of transparency or consistency we maintain. Some products, especially ex-import or rebatched materials, arrive with little process traceability. This exposes users to unexpected batch variability, inconsistent physical properties, and even undetected contamination. Bungarus Parvus differs through its old-fashioned hands-on manufacturing combined with up-to-date analytical documentation.

    Distributors and resellers often pool material from several unknown sources. Our process remains vertically integrated, with no blind relabeling or subcontracted processing steps, so every bag can be tracked to a specific batch record. We handle everything—from raw chemical synthesis through final drying and packing—under one roof.

    Many generic APIs targeting the veterinary sector use cost-cutting steps that leave physical and chemical properties inconsistent. We avoid cheap excipients and do not allow "fillers" to creep into primary lots. Our API batches survive the full range of industrial mixing, direct tableting, and solution compounding stress tests without complaint from downstream QC teams.

    Supporting Evidence From the Field

    Feedback from manufacturers and compounding pharmacies points to a substantial reduction in line stoppage time, particularly during scale-up. Animals in clinical settings respond consistently, with dosing outcomes matching calculated theoretical exposure based on milligrams delivered. Formulators have commented on the ability to move from small pilot batches to full commercial output without mess, equipment fouling, or lot-to-lot variability.

    Veterinary regulatory inspections go smoother with transparent documentation, impurity reports, and validated stability data supplied up front. Facilities in South America and Europe confirm shorter production turnarounds as less time is spent troubleshooting materials. Field veterinarians see less variability in outcome, especially when treating livestock herds or companion animals on regulated, time-limited dosing regimens.

    Technical Considerations: How It Performs

    Since veterinary APIs must meet stringent requirements for different species, Bungarus Parvus is manufactured with animal safety and predictable therapeutic response in mind. Stability testing accounts for climate and storage differences worldwide—not just shelf life in temperate regions. For tablet and capsule production, no extra steps are needed to overcome static or excessive fines in the powder. Our engineers work directly with customer QA teams to fine-tune grades, avoiding problems with compressibility or lubrication in high-speed presses.

    For injectable and oral solution formulations, solubility represents a common bottleneck. Bungarus Parvus dissolves efficiently in standard veterinary solvents, with no visible undissolved residue after routine mixing and filtration. This means fewer rejections for particulate and less filtration downtime. Documentation for dissolution, particle size, and impurity results is available to support regulatory submissions as required.

    Premix and feed formulation teams depend on batch-to-batch physical homogeneity for accurate dosing. Inconsistent API flow or agglomeration can lead to failures in metered dosing systems. Our attention to bulk density and moisture means powders blend rapidly with other feed ingredients and resist clumping, even during extended storage or transport under humid conditions.

    Thermal stability is another concern in many geographies. Bungarus Parvus holds up to typical temperature swings seen in storage sheds, transport containers, and field use without significant degradation. This practical resilience matters more than perfect laboratory data—handling during hot summer months or in uncooled containers tests every manufacturing promise.

    Compliance and Quality Verification

    Batch documentation follows international veterinary pharmaceutical standards, with impurity limits and residual solvents held well below published species-specific guidelines. Validation data, including microbial and endotoxin testing, is available for user review before purchase and can be included with each delivery for on-site confirmation.

    Internal audits keep our process aligned with ongoing regulatory changes. We train technical staff in both classic and modern analytical techniques; HPLC, GC-MS, and wet chemistry. That means discrepancies get resolved with real expertise, not guesswork or finger-pointing between outside laboratories.

    We handle all regulatory paperwork, including export certificates and statements of compliance, directly. This approach reduces the "black box" effect commonly faced by users dealing with repacked, anonymous APIs from third-party consolidators. Field feedback always comes back to one point—our buyers trust that the product shipped last month will match the one received today, next quarter, next year.

    Direct Access: The Manufacturer’s Advantage

    Users working directly with us as manufacturer benefit from straight access to the source of all technical support and documentation. Problems, questions, and requests for custom specifications receive immediate answers. Many veterinary API buyers cite frustrations with receiving generic answers or waiting on paperwork from overseas brokers. We supply prompt material tracebacks and tailored recommendations built on the experience of real production chemists and engineers.

    In cases of formulation troubleshooting, our technical team engages directly with the client’s QA and production staff, whether that involves blending trials, analytical support, or on-site visits. This direct partnership approach—unusual in today’s globalized API market—keeps information clear and solves problems without the delays caused by indirect communication chains.

    The feedback loop runs both ways. Client successes and failures guide our process upgrades. Our documentation changes, grade expansions, and new packaging options all stem from conversations with the actual teams in charge of formulation, blending, or regulatory compliance.

    Environmental and Safety Stewardship

    In production, chemical safety and environmental protection get daily attention. Bungarus Parvus is produced under careful control of waste streams, and all batches undergo residual solvent checks using established environmental safety protocols. Our staff handles reagents using best practices, and we regularly audit air and water emissions to maintain safe levels well below allowed thresholds.

    Worker safety on our plant floor represents a core value. Repurposed manufacturing lines and proper ventilation mean minimal exposure for our crew, and all batches get triple-checked before release to confirm safe handling for packing and shipping. This in-house commitment results in fewer incidents and a stronger reputation with both regional and international safety regulators.

    Packing, Storage, and Transportation

    We ship Bungarus Parvus in tamper-evident packaging, sealed against moisture and cross-contamination. Bulk powders go out in lined fiber drums or multi-wall bags, each labeled for full traceability by batch and lot. Smaller lots for specialty pharmacies use HDPE bottles with secondary wrapping, so shipping damage or external contamination never threaten the contents.

    Storage recommendations are practical—our material holds up to room temperature, soching runs more smoothly. Down the line, users opening up new lots find powder flow and handling match expectation, with no need to juggle alternate drying cycles, anti-caking agents, or emergency equipment washes.

    Quality Through Continuous Feedback

    An API can only match real-world needs if information moves freely from end to end. We believe improvements stem from field results. While some suppliers stop after meeting test specifications, our work continues through on-site audits, regular customer surveys, and technical visits. These direct conversations drive every incremental upgrade in process, packaging, and support.

    A key difference for Bungarus Parvus users: access to early notification of any lot changes, supply shifts, or process technology advances. We give clients the certainty to plan production, regulatory submissions, and stock movement with confidence. This proactive partnership eliminates the uncertainty that comes from dealing with unseen supply chains and hidden intermediaries.

    Summary: Why Leading Veterinary Brands Choose Us

    Bungarus Parvus represents not just a chemical input, but the full lifecycle commitment of a manufacturer guided by decades of hands-on experience. Every batch is built for the unique demands of veterinary practitioners and finished dosage form manufacturers, from small pilot trials to full production runs. Quality does not only mean meeting a published certificate—real trust is earned through performance under pressure, day after day.

    Our technical, regulatory, and production partners rely on Bungarus Parvus for more than stable APIs. They come back for reliable supply, field support, and direct, clear answers—every inquiry reaches a chemist or engineer rather than a call center. Those relationships, built on candor and technical competency, account for the real difference in veterinary pharmaceutical results.

    We invite feedback and new technical challenges. Any issue that arises gets attention from the original innovators and operators behind the process, ensuring the next lot and next product meet the evolving needs of the veterinary pharmaceutical world.

    Top